1 / 20

Project Quit Tobacco International (QTI)

Project Quit Tobacco International (QTI). Mimi Nichter , Ph.D. University of Arizona School of Anthropology. Overview. Introduce Project Quit Tobacco International Provide a brief background on tobacco use and tobacco control in Turkey Discuss the current QTI project in Turkey.

kirti
Télécharger la présentation

Project Quit Tobacco International (QTI)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Project Quit Tobacco International (QTI) Mimi Nichter, Ph.D. University of Arizona School of Anthropology

  2. Overview • Introduce Project Quit Tobacco International • Provide a brief background on tobacco use and tobacco control in Turkey • Discuss the current QTI project in Turkey

  3. Project Quit Tobacco International (QTI) • A decade-long Fogarty NIH project in India & Indonesia to develop evidence–based culturally-sensitive cessation approaches • Conduct formative research to understand perceptions of tobacco harm and patterns of use • Establish relevance of cessation advice by addressing how smoking has contributed to a patient’s existing health problems, and how SHS places others in household at risk • Introduce community-based approaches to tobacco education and develop smoke-free home initiatives

  4. QTI: Illness-specific focus • Most patients and the general public have general knowledge that smoking causes lung cancer or COPD but do not associate health conditions such as diabetes or TB with smoking • Raise community consciousness about the harms of tobacco beyond general knowledge • Illness is a teachable moment • Patients may be more willing to quit at this time • Tailoring cessation advice to a patient’s condition and incorporating motivational interviewing enhances the effectiveness of cessation messages

  5. For more information on QTI India and Indonesia: www.quittobaccointernational.org *15 module curriculum for medical students *15 videos modeling brief interventions for specific illnesses *educational materials for laypersons *Our publications

  6. QTI TURKEY

  7. Turkey & Tobacco Control • Turkey was among first countries globally to ratify WHO’s FCTC • Considered a leader in Europe in tobacco control, with comprehensive smoke-free legislation and taxation on tobacco products • In 2013, lauded as the only country in the world to have implemented all of WHO’s six MPOWER tobacco control measures (Monitor, Protect, Offer Help, Warn, Enforce and Raise Taxes) • Tobacco use remains a key public health concern—causes at least 100,000 deaths per year

  8. Smoking Prevalence • Turkey is the 8th largest consumer of tobacco in the world • Smoking among men: 41%; Women: 13% • Turks are high level smokers; men smoke about 20 cigarettes per day; women 15 • Perception around Europe of a heavy smoker is one who “smokes like a Turk” • Among health care providers: 24% of general practitioners, 13% of specialists, 20% of nurses and midwives are regular smokers

  9. DownwardShiftin SmokingPrevalence Men Total Women

  10. Smoking Cessation in Turkey • Although tobacco cessation is a key component of Turkish Health Policy, cessation outcomes are not well documented • In 2011, Turkey opened cessation clinics around the country; 27 were located in government hospitals in Istanbul. • Overall there are 415 cessation clinics in the country which are all very understaffed. The country has 14 million smokers. • Cessation is only carried out by doctors and is highly medicalized –pharmacotherapy (Varenicline &/or Bupropion). When available through the national health care system it was distributed freely, but availability is sporadic. • Notably, medications were purchased by the Ministry of Health in large batches twice—both times around the time of election. • When the medications are depleted, patients can purchase them with a prescription. • Very little behavioral counseling offered in cessation clinics

  11. Efficacy of Cessation Clinics • Only one study has evaluated the efficacy of national cessation program (Celik et al., 2015) • Examined one year period (2011); randomly chose 16,500 people who had received free medication (64% varenicline/Champix; 36% Bupropion/Zyban) • 30% of Varenicline users and 25% of Bupropion users had quit and had not relapsed at one year • Those with hypertension, diabetes, and CVD were more likely to have successfully quit Celik et al. Nationwide smoking cessation treatment support program in Turkey, Health Policy 119(2015) 50-56.

  12. Increasing need for cessation services • Recent national survey results on quitting: 43% of smokers had tried to quit in past year, and 35% had thought about quitting • The desire to quit is on the rise • There is a need for more information/educationon the harm of tobacco • At present, people have a general sense that smoking is harmful for health and that it can cause lung cancer

  13. Project Overview: QTI Turkey • Overall goal is to extend the reach and depth of smoking cessation training within the Turkish healthcare system. • To create a cadre of nurses trained in tobacco cessation who are able to: • perform illness-specific as well as general cessation as part of their routine clinical practice • assist in the training of other nurses in their sub-specialties.

  14. Why Nurses? • Recent Cochrane Review of 35 trials found nursing interventions to help smokers quit have been effective in US, UK, Australia, China, and many European countries. • In QTI, goal to make cessation a normative part of curative as well as preventive care • Nurses not involved at present; assumed that doctors had received training

  15. Team Effort QTI-Turkey Team • Mark Nichter, Ph.D., MPH, University of Arizona • Prof AygulAkyuz, Koc University, Istanbul We also like to thank: • Assoc. Prof. M. AtillaUysal, Yedikule Research Hospital • Dr. ElifAltug, Amerikan Hospital • Assoc. Prof. TokerErguder, WHO Turkey For their support

  16. Thank You!

More Related